MedPath

Pharmaceutical Companies

Spero Therapeutics logo

Spero Therapeutics

🇺🇸United States
Ownership
Public
Established
2013-01-01
Employees
46
Market Cap
$74.5M
Website
http://www.sperotherapeutics.com
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare...

Oncolytics Biotech

🇨🇦Canada
Ownership
-
Established
-
Employees
26
Market Cap
$74.3M
Website
-
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor...
GENENTA SCIENCE SPA logo

GENENTA SCIENCE SPA

🇮🇹Italy
Ownership
Public
Established
2014-01-01
Employees
14
Market Cap
$74.3M
Website
http://www.genenta.com

SERINA THERAPEUTICS

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$73.8M
Website
-

GENELUX

🇫🇷France
Ownership
-
Established
-
Employees
-
Market Cap
$72.1M
Website
-

MediciNova

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$71.6M
Website
-
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes...

Precision BioSciences

🇺🇸United States
Ownership
-
Established
-
Employees
109
Market Cap
$70.2M
Website
-
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of...

CEL-SCI

🇺🇸United States
Ownership
-
Established
-
Employees
44
Market Cap
$68.8M
Website
-
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and...
Ownership
Public
Established
-
Employees
208
Market Cap
$67M
Website
http://www.protalix.com
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include...
MAIA Biotechnology logo

MAIA Biotechnology

🇺🇸United States
Ownership
Public
Established
2018-01-01
Employees
13
Market Cap
$66.9M
Website
http://maiabiotech.com
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug...
© Copyright 2025. All Rights Reserved by MedPath